Spencer I Danto

3PUBLICATIONS
0CO-AUTHORS
Other education not elsewhere classifiedAllergyToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 23, 2025
Reply.

Spencer I Danto, Elena Peeva

|Aug 30, 2024
Exploratory pharmacodynamics and efficacy of PF-06817024 in a Phase 1 study of patients with chronic rhinosinusitis and atopic dermatitis.

Spencer I Danto, Nikolaos Tsamandouras, Padma Reddy

|Dec 07, 2019
Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06650833, a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, in single and multiple ascending dose randomized phase 1 studies in healthy subjects.

Spencer I Danto, Negin Shojaee, Ravi Shankar P Singh

Pageof 1

Frequent Collaborators